Publications

Detailed Information

Identification and analysis of dominant negative mutants of RAIDD and PIDD

DC Field Value Language
dc.contributor.authorJang, Tae-Ho-
dc.contributor.authorBae, Ju Young-
dc.contributor.authorPark, Ok Kyoung-
dc.contributor.authorKim, Ji Hoe-
dc.contributor.authorPark, Hyun Ho-
dc.contributor.authorJeon, Ju-Hong-
dc.contributor.authorCho, Kyung-Hyun-
dc.date.accessioned2012-05-22T04:39:33Z-
dc.date.available2012-05-22T04:39:33Z-
dc.date.issued2010-07-
dc.identifier.citationBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS; Vol.1804 7; 1557-1563ko_KR
dc.identifier.issn1570-9639-
dc.identifier.urihttps://hdl.handle.net/10371/76220-
dc.description.abstractCaspases are cysteine proteases that are essential during the initiation and execution of apoptosis and inflammation. The formation of large oligomeric protein complexes is critical to the activation of caspases in apoptotic and inflammatory signaling pathways. These oligomeric protein complexes function as a platform to recruit caspases, which leads to caspase activation via a proximity-induced mechanism. One well-known oligomeric caspase-activating complex is the PIDDosome for caspase-2 activation, which is composed of 3 protein components, PIDD, RAIDD and Caspase-2. Despite the significant role that caspase-2 activated by PIDDosome plays during genotoxic stress-induced apoptosis, the oligomerization mechanism and the method by which the caspase-activating process is mediated by the formation of PIDDosome is currently not well understood. Here, we show that the assembly mechanism of the core of PIDDosome is time-dependent and salt concentration-dependent. In addition, we demonstrate that point mutations on RAIDD (R147E) and on PLOD (Y814A) exert a dominant negative effect on the formation of the PIDDosome, and that this effect cannot be applied after the PIDDosome has been formed. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectApoptosisko_KR
dc.subjectRAIDDko_KR
dc.subjectDominant negative mutantko_KR
dc.subjectPIDD PIDDosomeko_KR
dc.subjectDISCko_KR
dc.subjectInflammationko_KR
dc.subjectApoptosomeko_KR
dc.subjectCaspase-2ko_KR
dc.titleIdentification and analysis of dominant negative mutants of RAIDD and PIDDko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor장태호-
dc.contributor.AlternativeAuthor김지회-
dc.contributor.AlternativeAuthor조경현-
dc.contributor.AlternativeAuthor전주홍-
dc.contributor.AlternativeAuthor박현호-
dc.contributor.AlternativeAuthor박옥경-
dc.contributor.AlternativeAuthor배주영-
dc.identifier.doi10.1016/j.bbapap.2010.04.006-
dc.citation.journaltitleBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS-
dc.description.citedreferenceWajant H, 2003, ESSAYS BIOCHEM, V39, P53-
dc.description.citedreferenceNickoloff BJ, 2002, J INVEST DERM SYMP P, V7, P27-
dc.description.citedreferenceDenault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n-
dc.description.citedreferenceLassus P, 2002, SCIENCE, V297, P1352-
dc.description.citedreferenceMartinon F, 2002, MOL CELL, V10, P417-
dc.description.citedreferenceWajant H, 2002, SCIENCE, V296, P1635-
dc.description.citedreferenceSalvesen GS, 2002, ESSAYS BIOCHEM, V38, P9-
dc.description.citedreferenceTalapatra S, 2001, J PHARMACOL EXP THER, V298, P873-
dc.description.citedreferenceLin YP, 2000, NAT GENET, V26, P122-
dc.description.citedreferenceJanssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036-
dc.description.citedreferencePark HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082-
dc.description.citedreferencePark HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656-
dc.description.citedreferencePark HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019-
dc.description.citedreferencePark HH, 2007, ACTA CRYSTALLOGR F, V63, P229, DOI 10.1107/S1744309107007889-
dc.description.citedreferenceSalvesen GS, 2008, ADV EXP MED BIOL, V615, P13-
dc.description.citedreferenceDENAULT JB, 2008, METH MOL B, V414, P191-
dc.description.citedreferenceMartinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715-
dc.description.citedreferenceJang TH, 2009, INT J MOL SCI, V10, P2501, DOI 10.3390/ijms10062501-
dc.description.citedreferenceGudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992-
dc.description.citedreferenceBoatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009-
dc.description.citedreferenceREED JC, 2004, SCI STKE, pRE9, DOI DOI 10.1126/STKE.2392004RE9-
dc.description.citedreferenceTinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432-
dc.description.citedreferenceMartinon F, 2004, CELL, V117, P561-
dc.description.citedreferenceZhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191-
dc.description.citedreferenceGudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726-
dc.description.citedreferenceWu ZH, 2005, CELL, V123, P980, DOI 10.1016/j.cell.2005.11.025-
dc.description.citedreferenceTelliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280-
dc.description.citedreferenceStennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299-
dc.description.citedreferenceThompson TC, 2000, PROSTATE, P25-
dc.description.citedreferenceStennicke HR, 1999, CELL DEATH DIFFER, V6, P1054-
dc.description.citedreferenceKomarov PG, 1999, SCIENCE, V285, P1733-
dc.description.citedreferenceZou H, 1999, J BIOL CHEM, V274, P11549-
dc.description.citedreferenceRathmell JC, 1999, ANNU REV IMMUNOL, V17, P781-
dc.description.citedreferenceKelliher MA, 1998, IMMUNITY, V8, P297-
dc.description.citedreferenceZou H, 1997, CELL, V90, P405-
dc.description.citedreferenceDuan H, 1997, NATURE, V385, P86-
dc.description.citedreferenceRudin CM, 1997, ANNU REV MED, V48, P267-
dc.description.citedreferenceHsu HL, 1996, IMMUNITY, V4, P387-
dc.description.citedreferenceWANG L, 1994, CELL, V78, P739-
dc.description.citedreferenceWYLLIE AH, 1980, INT REV CYTOL, V68, P251-
dc.description.citedreferenceKERR JFR, 1972, BRIT J CANCER, V26, P239-
dc.description.tc4-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share